<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04616365</url>
  </required_header>
  <id_info>
    <org_study_id>19-6364</org_study_id>
    <nct_id>NCT04616365</nct_id>
  </id_info>
  <brief_title>Planned Semi-Elective Lung Tx Study</brief_title>
  <official_title>Planned Semi-Elective Lung Transplantation Using 10°C Cold Static Preservation: A Proof-Of-Concept Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the current practice of lung transplantation, transplants are performed on a 24/7 schedule&#xD;
      with a significant amount of procedures occurring overnight in order to minimize organ&#xD;
      ischemic time. However, transplantation during the day time may lead to several advantages&#xD;
      related to patient safety, including the presence of rested staff performing optimally,&#xD;
      larger number of in-house professionals for emergency situations, and professional&#xD;
      well-being. Advances and refinements in preservation practices have evolved to show that&#xD;
      extended periods of preservation can be achieved without compromising outcome. Based on this,&#xD;
      it is hypothesized that the avoidance of &quot;after-hours&quot; (10PM-4AM) lung transplantation&#xD;
      through prolonged pulmonary preservation will lead to at least similar patient outcomes&#xD;
      compared to the current practice of 24/7 transplantation. During the period of this study,&#xD;
      overnight transplants will be moved to a later start time (earliest 6AM). If lungs meet&#xD;
      criteria for direct transplantation, they will be preserved with cold static preservation at&#xD;
      10°C within a special refrigerator. The maximum preservation time from donor cold flush to&#xD;
      recipient anesthesia start time will be 12 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 26, 2020</start_date>
  <completion_date type="Anticipated">August 26, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 26, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of ISHLT Primary Graft Dysfunction Grade 3</measure>
    <time_frame>72 hours post-transplant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>30 days, 1 year post-transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time on ventilator</measure>
    <time_frame>Perioperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>Perioperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of acute rejection</measure>
    <time_frame>1 year post-transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six minute walk test</measure>
    <time_frame>1 year post-transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume - one second (FEV1 in L)</measure>
    <time_frame>1 year post-transplant</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Lung Transplantation</condition>
  <arm_group>
    <arm_group_label>Semi-Elective Lung Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Planned Semi-Elective Lung Transplantation Using 10°C Cold Static Preservation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Semi-Elective Lung Transplantation</intervention_name>
    <description>When suitable donor lungs become available for a consented recipient, and the donor cross clamp time occurs between 6PM and 4AM, the transplant procedure (anesthesia starting time) will be allowed to be moved to a 6AM start or later with the lungs being preserved at 10°C cold static preservation upon arrival to our hospital using a specific incubator. The maximum allowed time between donor cross clamp and recipient anesthesia initiation will be 12 hours.</description>
    <arm_group_label>Semi-Elective Lung Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Recipient inclusion criteria&#xD;
&#xD;
          -  Primary lung transplantation&#xD;
&#xD;
          -  Informed consent provided&#xD;
&#xD;
          -  18-80 years old&#xD;
&#xD;
        Recipient exclusion criteria&#xD;
&#xD;
          -  Re-transplantation&#xD;
&#xD;
          -  Multi-organ transplantation&#xD;
&#xD;
          -  &gt;80 years old&#xD;
&#xD;
        Donor inclusion criteria&#xD;
&#xD;
          -  Age ≤70 years old&#xD;
&#xD;
          -  Donor lungs are suitable to go straight to lung transplantation&#xD;
&#xD;
          -  Cross-clamp between 6PM-4AM&#xD;
&#xD;
        Donor exclusion criteria&#xD;
&#xD;
          -  Age &gt;70 years old&#xD;
&#xD;
          -  Concerns with organ preservation technique&#xD;
&#xD;
          -  Donor lungs require assessment by Ex Vivo Lung Perfusion (EVLP)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo Cypel, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sharaniyaa Balachandran</last_name>
    <phone>416-340-4800</phone>
    <phone_ext>6549</phone_ext>
    <email>sharaniyaa.balachandran@uhn.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network (Toronto General Hospital)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharaniyaa Balachandran</last_name>
      <phone>416-340-4800</phone>
      <phone_ext>6549</phone_ext>
      <email>sharaniyaa.balachandran@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Marcelo Cypel, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

